478 results on '"Scagliotti Giorgio, V"'
Search Results
2. Exploring circular MET RNA as a potential biomarker in tumors exhibiting high MET activity
3. The International Association for the Study of Lung Cancer Early Lung Imaging Confederation Open-Source Deep Learning and Quantitative Measurement Initiative
4. Tumor plasticity and therapeutic resistance in oncogene-addicted non-small cell lung cancer: from preclinical observations to clinical implications
5. International Association for the Study of Lung Cancer Study of the Impact of Coronavirus Disease 2019 on International Lung Cancer Clinical Trials
6. Experience with denosumab (XGEVA®) for prevention of skeletal-related events in the 10 years after approval
7. Liquid Biopsy for Advanced NSCLC: A Consensus Statement From the International Association for the Study of Lung Cancer
8. Talazoparib monotherapy in metastatic castration-resistant prostate cancer with DNA repair alterations (TALAPRO-1): an open-label, phase 2 trial
9. DNA Methylation Profiling Discriminates between Malignant Pleural Mesothelioma and Neoplastic or Reactive Histologic Mimics
10. Prognostic role of the duration of response to androgen deprivation therapy in patients with metastatic castration resistant prostate cancer treated with enzalutamide or abiraterone acetate
11. The International Association for the Study of Lung Cancer Global Survey on Molecular Testing in Lung Cancer
12. Double immune checkpoint blockade in advanced NSCLC
13. Treatment Guidance for Patients With Lung Cancer During the Coronavirus 2019 Pandemic
14. Immune Checkpoint Inhibitors in Thoracic Malignancies: Review of the Existing Evidence by an IASLC Expert Panel and Recommendations
15. Final Overall Survival and Other Efficacy and Safety Results From ASCEND-3: Phase II Study of Ceritinib in ALKi-Naive Patients With ALK-Rearranged NSCLC
16. Quality of life assessment and reporting in colorectal cancer: A systematic review of phase III trials published between 2012 and 2018
17. Quality of life analysis in lung cancer: A systematic review of phase III trials published between 2012 and 2018
18. Definition of Synchronous Oligometastatic Non–Small Cell Lung Cancer—A Consensus Report
19. Quality-of-Life Assessment and Reporting in Prostate Cancer: Systematic Review of Phase 3 Trials Testing Anticancer Drugs Published Between 2012 and 2018
20. Potential Diagnostic and Prognostic Role of Microenvironment in Malignant Pleural Mesothelioma
21. Nintedanib in combination with pemetrexed and cisplatin for chemotherapy-naive patients with advanced malignant pleural mesothelioma (LUME-Meso): a double-blind, randomised, placebo-controlled phase 3 trial
22. Targeting angiogenesis for patients with unresectable malignant pleural mesothelioma
23. Current Status and Future Perspectives on Neoadjuvant Therapy in Lung Cancer
24. Liquid Biopsy for Advanced Non-Small Cell Lung Cancer (NSCLC): A Statement Paper from the IASLC
25. Update on International Cooperative Groups Studies in Thoracic Malignancies: The Emergence of Immunotherapy
26. Chemotherapy-Induced Neutropenia and Outcome in Patients With Metastatic Castration-Resistant Prostate Cancer Treated With First-Line Docetaxel
27. Loss of C/EBP-β LIP drives cisplatin resistance in malignant pleural mesothelioma
28. Molecular and Histopathological Characterization of the Tumor Immune Microenvironment in Advanced Stage of Malignant Pleural Mesothelioma
29. Multicenter Comparison of 22C3 PharmDx (Agilent) and SP263 (Ventana) Assays to Test PD-L1 Expression for NSCLC Patients to Be Treated with Immune Checkpoint Inhibitors
30. Safety Analyses of Pemetrexed-cisplatin and Pemetrexed Maintenance Therapies in Patients With Advanced Non-squamous NSCLC: Retrospective Analyses From 2 Phase III Studies
31. Scientific Advances in Thoracic Oncology 2016
32. Molecular biomarkers to predict response to neoadjuvant chemotherapy for bladder cancer
33. Neuroendocrine breast carcinoma: a rare but challenging entity
34. Meta-analysis examining impact of age on overall survival with pemetrexed for the treatment of advanced non-squamous non-small cell lung cancer
35. Lung cancer: current therapies and new targeted treatments
36. Scientific Advances in Lung Cancer 2015
37. Skeletal metastases and impact of anticancer and bone-targeted agents in patients with castration-resistant prostate cancer
38. Papillary renal cell carcinoma: A review of the current therapeutic landscape
39. Phase I Study of Lapatinib and Pemetrexed in the Second-Line Treatment of Advanced or Metastatic Non–Small-Cell Lung Cancer With Assessment of Circulating Cell Free Thymidylate Synthase RNA as a Potential Biomarker
40. Targeted Next-Generation Sequencing of Cancer Genes in Advanced Stage Malignant Pleural Mesothelioma: A Retrospective Study
41. Tissue Expression and Pharmacological In Vitro Analyses of mTOR and SSTR Pathways in Adrenocortical Carcinoma
42. Autocrine 17-β-estradiol/estrogen receptor-α loop determines the response to immune-checkpoint inhibitors in non-small cell lung cancer
43. Impact of Non–Small-Cell Lung Cancer-Not Otherwise Specified Immunophenotyping on Treatment Outcome
44. Motesanib Plus Carboplatin/Paclitaxel in Patients With Advanced Squamous Non–Small-Cell Lung Cancer: Results From the Randomized Controlled MONET1 Study
45. MicroRNA expression patterns in adrenocortical carcinoma variants and clinical pathologic correlations
46. FOLFOX activity in a rare case of metastatic colonic adenocarcinoma of the tongue: a case report
47. An Open-Label, Multicenter, Randomized, Phase II Study of Pazopanib in Combination with Pemetrexed in First-Line Treatment of Patients with Advanced-Stage Non–Small-Cell Lung Cancer
48. The emerging role of MET/HGF inhibitors in oncology
49. Early Response to Chemotherapy in Patients With Non–Small-Cell Lung Cancer Assessed by [18F]-Fluoro-Deoxy-D-Glucose Positron Emission Tomography and Computed Tomography
50. Messenger RNA and protein expression of thymidylate synthase and DNA repair genes in thymic tumors
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.